Leveraging speech and artificial intelligence to screen for early Alzheimer's disease and amyloid beta positivity
Open accessThe DOI matches its Crossref record; 52 of the 55 references it cites were found in a registry or an index.
Abstract
Early detection of Alzheimer’s disease is required to identify patients suitable for disease-modifying medications and to improve access to non-pharmacological preventative interventions. Prior research shows detectable changes in speech in Alzheimer’s dementia and its clinical precursors. The current study assesses whether a fully automated speech-based artificial intelligence system can detect cognitive impairment and amyloid beta positivity, which characterize early stages of Alzheimer’s disease. Two hundred participants (age 54–85, mean 70.6; 114 female, 86 male) from sister studies in the UK (NCT04828122) and the USA (NCT04928976), completed the same assessments and were combined in the current analyses. Participants were recruited from prior clinical trials where amyloid beta status (97 amyloid positive, 103 amyloid negative, as established via PET or CSF test) and clinical diagnostic status was known (94 cognitively unimpaired, 106 with mild cognitive impairment or mild Alzheimer’s disease). The automatic story recall task was administered during supervised in-person or telemedicine assessments, where participants were asked to recall stories immediately and after a brief delay. An artificial intelligence text-pair evaluation model produced vector-based outputs from the original story text and recorded and transcribed participant recalls, quantifying differences between them. Vector-based representations were fed into logistic regression models, trained with tournament leave-pair-out cross-validation analysis to predict amyloid beta status (primary endpoint), mild cognitive impairment and amyloid beta status in diagnostic subgroups (secondary endpoints). Predictions were assessed by the area under the receiver operating characteristic curve for the test result in comparison with reference standards (diagnostic and amyloid status). Simulation analysis evaluated two potential benefits of speech-based screening: (i) mild cognitive impairment screening in primary care compared with the Mini-Mental State Exam, and (ii) pre-screening prior to PET scanning when identifying an amyloid positive sample. Speech-based screening predicted amyloid beta positivity (area under the curve = 0.77) and mild cognitive impairment or mild Alzheimer’s disease (area under the curve = 0.83) in the full sample, and predicted amyloid beta in subsamples (mild cognitive impairment or mild Alzheimer’s disease: area under the curve = 0.82; cognitively unimpaired: area under the curve = 0.71). Simulation analyses indicated that in primary care, speech-based screening could modestly improve detection of mild cognitive impairment (+8.5%), while reducing false positives (−59.1%). Furthermore, speech-based amyloid pre-screening was estimated to reduce the number of PET scans required by 35.3% and 35.5% in individuals with mild cognitive impairment and cognitively unimpaired individuals, respectively. Speech-based assessment offers accessible and scalable screening for mild cognitive impairment and amyloid beta positivity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“while in the semantic variant PPA, spontaneous speech is fluent but marked by semantic errors, reduced specificity, and loss of content due to degradation of conceptual knowledge.90”
From Review of Artificial Intelligence for Clinical Use in Alzheimer's Disease and Related Dementias (2026) · cites this paper as [90]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., Brayne, C., Burns, A., Cohen-Mansfield, J., Cooper, C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30367-6 · Cited by 10,430
RetractedFolstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282 · cited 7×
“31 The composite includes summary scores from five measures: (i) the MMSE, 29 a global cognitive screening test; (ii) the Logical Memory Delayed Recall, 8,32 a delayed story recall test; (iii) Digit-Symbol Coding, 33 a symbol sub-stitution test; (iv) the sum of free and total recall from the Free…”
InfluentialHirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · Brain and nerve · Cited by 21,038
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Older Adults' Reasons for Using Technology while Aging in Place
Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J. M., & Wouters, E. J. M. (2016) · Gerontology · doi:10.1159/000430949 · Cited by 19,690
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. (2015) · Gerontology · doi:10.1159/000362720 · Cited by 18,909
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882 · cited 1×
“…English as a first language; availability of a study partner to support completing the Clinical Dementia Rating scale (CDR) semi-structured interview 30 ; ability to use and access a smartphone (Android 7 or above or iOS 11 or above), for a fully remote component of the study reported elsewhere.”
Longformer: The Long-Document Transformer
Beltagy, I., Peters, M. E., & Cohan, A. (2020) · arXiv · doi:10.48550/arxiv.2004.05150 · Cited by 2,281
Villemagne, V. L., Burnham, S., Bourgeat, P., Brown, B., Ellis, K. A., Salvado, O., Szoeke, C., Macaulay, S. L., Martins, R., Maruff, P., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70044-9 · Cited by 2,279
Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia: A Meta-analysis
Jansen, W. J., Ossenkoppele, R., Knol, D. L., Tijms, B. M., Scheltens, P., Verhey, F. R. J., Visser, P. J., Aalten, P., Aarsland, D., Alcolea, D., et al. (2015) · JAMA · doi:10.1001/jama.2015.4668 · Cited by 1,610 · cited 5×
“Since A β positivity increases with age, 43 conversion may have occurred for some participants in the interim period.”
InfluentialWAIS-R manual : Wechsler adult intelligence scale-revised
Wechsler, D. (1981) · Medical Entomology and Zoology · Cited by 1,559
Mitchell, A. J. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.04.014 · Cited by 1,129 · cited 1×
“44 Furthermore, following methods described by Keshavan et al ., 45 the proportion of PET scans required and the number of participants recruited during pre-screening with the ASRT system was modelled compared with routine PET scanning to deliver a pre-specified sample size.”
Blood-based biomarkers for Alzheimer's disease: towards clinical implementation
Teunissen, C. E., Verberk, I. M. W., Thijssen, E. H., Vermunt, L., Hansson, O., Zetterberg, H., van der Flier, W. M., Mielke, M. M., & del Campo, M. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00361-6 · Cited by 1,045 · cited 1×
“52 However, research to date indicates that blood-based biomarkers do not differentiate clinical stages of the disease well, 53 which indicates that even with further improvement in the sensitivity and consistency of blood-based testing a continued need for cognitive and clinical assessment will…”
Understanding receiver operating characteristic (ROC) curves
Fan, J., Upadhye, S., & Worster, A. (2006) · CJEM · doi:10.1017/s1481803500013336 · Cited by 840
Sun, X., & Xu, W. (2014) · IEEE Signal Processing Letters · doi:10.1109/lsp.2014.2337313 · Cited by 630
Connected speech as a marker of disease progression in autopsy-proven Alzheimer’s disease
Ahmed, S., Haigh, A.-M. F., de Jager, C. A., & Garrard, P. (2013) · Brain · doi:10.1093/brain/awt269 · Cited by 362 · cited 1×
“…of speech in Alzheimer’s disease (including for example, pronoun rate, speech rate, dysfluencies, or partial words), are often manually scored, 15,16 More recently, speech features have been automatically extracted via nat-ural language processing methods, 17–20 some of which have been found…”
Datasets: A Community Library for Natural Language Processing
Lhoest, Q., Villanova del Moral, A., Jernite, Y., Thakur, A., von Platen, P., Patil, S., Chaumond, J., Drame, M., Plu, J., Tunstall, L., et al. (2021) · Proceedings of the 2021 Conference on Empirical Methods in Natural Language Processing: System Demonstrations · doi:10.18653/v1/2021.emnlp-demo.21 · Cited by 343 · cited 1×
“The word error rate (WER) of the automatic transcript was calculated using the HuggingFace package 39 as the average number of errors per manual transcript word.”
Connolly, A., Gaehl, E., Martin, H., Morris, J., & Purandare, N. (2011) · Aging & Mental Health · doi:10.1080/13607863.2011.596805 · Cited by 307
Optimizing the preclinical Alzheimer's cognitive composite with semantic processing: The PACC5
Papp, K. V., Rentz, D. M., Orlovsky, I., Sperling, R. A., & Mormino, E. C. (2017) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2017.10.004 · Cited by 303 · cited 1×
“31 The composite includes summary scores from five measures: (i) the MMSE, 29 a global cognitive screening test; (ii) the Logical Memory Delayed Recall, 8,32 a delayed story recall test; (iii) Digit-Symbol Coding, 33 a symbol sub-stitution test; (iv) the sum of free and total recall from the Free…”
Self-citationGarcía, S. D. L. F., Ritchie, C. W., & Luz, S. F. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2010.06047 · Cited by 265 · cited 2×
“12 More recent methodologies use a data-driven approach to learn patterns directly from raw audio and transcript speech data.”
Martínez-Nicolás, I., Llorente, T. E., Martínez-Sánchez, F., & Meilán, J. J. G. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.620251 · Cited by 180 · cited 2×
“11 Our simulation analyses evaluate hypothetical savings in clinician resources and PET scans given the sensitivity and specificity of the ASRT system test results derived in the current study.”
Airola, A., Pahikkala, T., Waegeman, W., De Baets, B., & Salakoski, T. (2011) · Computational Statistics & Data Analysis · doi:10.1016/j.csda.2010.11.018 · Cited by 166 · cited 1×
“27 In tournament leave-pair-out cross-validation analysis, every possible pair of data points is held out in turn while the model is trained using all other data points.”
Mini Mental State Examination and Logical Memory scores for entry into Alzheimer’s disease trials
Chapman, K. R., Bing-Canar, H., Alosco, M. L., Steinberg, E. G., Martin, B., Chaisson, C., Kowall, N., Tripodis, Y., & Stern, R. A. (2016) · Alzheimer's Research & Therapy · doi:10.1186/s13195-016-0176-z · Cited by 152
The Free and Cued Selective Reminding Test: evidence of psychometric adequacy
Grober, E. H., Ocepek‐Welikson, K., & Teresi, J. A. (2009) · Psychology science · Cited by 103
(2020) · Brain · doi:10.1093/brain/awaa403 · Cited by 103 · cited 1×
“44 Furthermore, following methods described by Keshavan et al ., 45 the proportion of PET scans required and the number of participants recruited during pre-screening with the ASRT system was modelled compared with routine PET scanning to deliver a pre-specified sample size.”
Tsoi, K. K. F., Chan, J. Y. C., Hirai, H. W., Wong, A., Mok, V., LAM, L. C. W., Kwok, T. C. Y., & Wong, S. Y. S. (2017) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.05.016 · Cited by 96 · cited 1×
“46 In the current study, the ASRT system is superseded by the PACC5 cognitive composite for detecting MCI.”
Keshavan, A., Pannee, J., Karikari, T. K., Rodriguez, J. L., Ashton, N. J., Nicholas, J. M., Cash, D. M., Coath, W., & Lane, C. A. (2022) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2022-abn.297 · Cited by 94
Alyahya, R. S. W., Halai, A. D., Conroy, P., & Lambon Ralph, M. A. (2020) · Brain · doi:10.1093/brain/awaa074 · Cited by 91 · cited 2×
“23 As well as being sensitive to episodic memory impairments, evidence suggests that speech produced during narrative discourse tasks elicit more content rich and varied speech, 24 and show better differentiation of early Alzheimer’s than other speech sampling strategies.”
Tosun, D., Veitch, D., Aisen, P., Jack, C. R., Jagust, W. J., Petersen, R. C., Saykin, A. J., Bollinger, J., Ovod, V., Mawuenyega, K. G., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab008 · Cited by 79 · cited 1×
“52 However, research to date indicates that blood-based biomarkers do not differentiate clinical stages of the disease well, 53 which indicates that even with further improvement in the sensitivity and consistency of blood-based testing a continued need for cognitive and clinical assessment will…”
Exploring Deep Transfer Learning Techniques for Alzheimer's Dementia Detection
Zhu, Y., Liang, X., Batsis, J. A., & Roth, R. M. (2021) · Frontiers in Computer Science · doi:10.3389/fcomp.2021.624683 · Cited by 77 · cited 1×
“22 The fine-tuning approach is typical for larger datasets (i.e. thousands of examples) but can be unstable on the small datasets that are typical of clinical studies.”
Onyeaka, H., Romero, P. M., Healy, B. C., & Celano, C. M. (2020) · Journal of Aging and Health · doi:10.1177/0898264320966266 · Cited by 74 · cited 1×
“56 While our findings, based on a combined UK and US sample, indicate that the robust results can be achieved across different geographical locations and accents, replication and, ideally, out-of-sample validation in larger, more clinically and demo-graphically heterogeneous samples is now needed.”
Using Digital Speech Assessments to Detect Early Signs of Cognitive Impairment
Robin, J., Xu, M., Kaufman, L. D., & Simpson, W. (2021) · Frontiers in Digital Health · doi:10.3389/fdgth.2021.749758 · Cited by 67
The Computerized Cognitive Composite (C3) in A4, an Alzheimer's Disease Secondary Prevention Trial
Papp, K. V., Rentz, D. M., Maruff, P., Sun, C.-K., Raman, R., Donohue, M. C., Schembri, A., Stark, C., Yassa, M. A., Wessels, A. M., et al. (2021) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2020.38 · Cited by 66
Self-citationClarke, N., Barrick, T. R., & Garrard, P. (2021) · Frontiers in Computer Science · doi:10.3389/fcomp.2021.634360 · Cited by 65 · cited 1×
“25 Further, direct comparison of a story source text with the spoken recall allows for the identification of para-phrases and repetitions, tracking of insertions such as filled pauses or commentary, omissions, or changes in the order or content of the story.”
Association of CSF Aβ, amyloid PET, and cognition in cognitively unimpaired elderly adults
Guo, T., Shaw, L. M., Trojanowski, J. Q., Jagust, W. J., Landau, S. M., & Initiative, F. T. A. D. N. (2020) · Neurology · doi:10.1212/wnl.0000000000010596 · Cited by 51 · cited 1×
“54 Variation in biomarker and diagnostic criteria (between trials where participants were recruited from) is likely to have introduced increased variability in our diagnostic reference standards.”
Lexical and Acoustic Speech Features Relating to Alzheimer Disease Pathology
Cho, S., Cousins, K. A. Q., Shellikeri, S., Ash, S., Irwin, D. J., Liberman, M. Y., Grossman, M., & Nevler, N. (2022) · Neurology · doi:10.1212/wnl.0000000000200581 · Cited by 51 · cited 3×
“…example, pronoun rate, speech rate, dysfluencies, or partial words), are often manually scored, 15,16 More recently, speech features have been automatically extracted via nat-ural language processing methods, 17–20 some of which have been found to correlate with CSF phosphorylated tau biomarkers.”
Pauses for Detection of Alzheimer’s Disease
Yuan, J., Cai, X., Bian, Y., Ye, Z., & Church, K. (2021) · Frontiers in Computer Science · doi:10.3389/fcomp.2020.624488 · Cited by 49 · cited 1×
“…pre-trained Transformer models to make predictions on downstream tasks: attaching a prediction head to a later layer of the Transformer and fine-tuning the entire network, 21 or using the output at a later layer as a fixed feature extractor and using these features as input to a separate model.”
Time between milestone events in the Alzheimer's disease amyloid cascade
Insel, P. S., Donohue, M. C., Berron, D., Hansson, O., & Mattsson-Carlgren, N. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2020.117676 · Cited by 48
Mueller, K. D., Koscik, R. L., Du, L., Bruno, D., Jonaitis, E. M., Koscik, A. Z., Christian, B. T., Betthauser, T. J., Chin, N. A., Hermann, B. P., et al. (2020) · Cortex · doi:10.1016/j.cortex.2020.07.008 · Cited by 41
Predicting Amyloid Burden to Accelerate Recruitment of Secondary Prevention Clinical Trials
Langford, O., Raman, R., Sperling, R. A., Cummings, J., Sun, C.-K., Jimenez-Maggiora, G., Aisen, P. S., & Donohue, M. C. (2020) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2020.44 · Cited by 41 · cited 2×
“Research indicates that traditional cognitive tests and cognitive composites, although sensitive to cognitive decline, on their own show more modest differentiation between amyloid positive and negative individuals, 47–49 reflected also in the current results.”
InfluentialSkirrow, C., Meszaros, M., Meepegama, U., Lenain, R., Papp, K. V., Weston, J., & Fristed, E. (2022) · JMIR Aging · doi:10.2196/37090 · Cited by 35
Self-citationSerial position effects in the Logical Memory Test: Loss of primacy predicts amyloid positivity
Bruno, D., Mueller, K. D., Betthauser, T. J., Chin, N. A., Engelman, C. D., Christian, B. T., Koscik, R. L., & Johnson, S. C. (2020) · Journal of Neuropsychology · doi:10.1111/jnp.12235 · Cited by 30 · cited 2×
“10 For detecting MCI, the ASRT system also performs similarly to a range of other available traditional cognitive tests, as shown in prior meta-analysis (AUC 0.70–0.94, mean AUC across tests evaluated AUC = 0.81).”
InfluentialTsoy, E., Strom, A., Iaccarino, L., Erlhoff, S. J., Goode, C. A., Rodriguez, A.-M., Rabinovici, G. D., Miller, B. L., Kramer, J. H., Rankin, K. P., et al. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00776-w · Cited by 26 · cited 2×
“Research indicates that traditional cognitive tests and cognitive composites, although sensitive to cognitive decline, on their own show more modest differentiation between amyloid positive and negative individuals, 47–49 reflected also in the current results.”
Montgomery, V., Harris, K., Stabler, A., & Lu, L. H. (2017) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acx005 · Cited by 15 · cited 1×
“5 Story recall differentiates individuals with mild cognitive impairment (MCI; an earlier stage of the disease), from those that are cognitively unimpaired (CU) 6 and is commonly used for screening into Alzheimer’s disease trials.”
Porto, M. F., Benítez-Agudelo, J. C., Aguirre–Acevedo, D. C., Barceló, E., & Allegri, R. (2021) · Applied Neuropsychology Adult · doi:10.1080/23279095.2021.1897007 · Cited by 12
A Comparison of Speech Features between Mild Cognitive Impairment and Healthy Aging Groups
Kim, K. W., Na, S., Chung, Y., & Shin, B. (2021) · Dementia and Neurocognitive Disorders · doi:10.12779/dnd.2021.20.4.52 · Cited by 12 · cited 1×
“…of speech in Alzheimer’s disease (including for example, pronoun rate, speech rate, dysfluencies, or partial words), are often manually scored, 15,16 More recently, speech features have been automatically extracted via nat-ural language processing methods, 17–20 some of which have been found to…”
Aducanumab and the Business of Alzheimer Disease-Some Choice.
Karlawish, J. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2021.3123 · Cited by 8 · cited 1×
“51 Treatments will primarily have been tested in patients with MCI or mild Alzheimer’s disease with elevated amyloid biomarkers and will likely be indicated in these populations.”
Prevalence Rates of Amyloid Positivity—Updates and Relevance
Young, C. B., & Mormino, E. C. (2022) · JAMA Neurology · doi:10.1001/jamaneurol.2021.5225 · Cited by 8 · cited 1×
“55 Similarly, the population under examination here showed limited ethnic or racial diversity ( N = 193 white, N = 3 Asian and N = 4 Black or African American), indicating that replication across a broader and more representative range of ethnic and racial backgrounds is required.”
de la Fuente Garcia, S., Ritchie, C. W., & Luz, S. (2020) · Journal of Alzheimer's Disease · doi:10.3233/jad-200888 · Cited by 5 · cited 2×
“12 More recent methodologies use a data-driven approach to learn patterns directly from raw audio and transcript speech data.”
Research works printed but not linked: 2
- Wechsler, 2008, WAIS-R Manual: Wechsler Adult Intelligence Scale-Revised
- Liu, 2019, RoBERTa: A robustly optimised BERT pretraining approach, arXiv
Cited by
Veneziani, I., Marra, A., Formica, C., Grimaldi, A., Marino, S., Quartarone, A., & Maresca, G. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14010113 · Cited by 54
“Notably, an automatically administered and analyzed screening speech-based test was able to predict Amyloid-β (A β ) positivity and MCI [43].”
Perceptions of Artificial Intelligence and ChatGPT by Speech-Language Pathologists and Students
Austin, J., Benas, K., Caicedo, S., Imiolek, E., Piekutowski, A., & Ghanim, I. (2025) · American Journal of Speech-Language Pathology · doi:10.1044/2024_ajslp-24-00218 · Cited by 31
Screening for early Alzheimer’s disease: enhancing diagnosis with linguistic features and biomarkers
Chou, C., Chang, C.-T., Chang, Y., Lee, C., Chuang, Y., Chiu, Y., Liang, W.-L., Fan, Y.-M., & Liu, Y. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1451326 · Cited by 34
Zarei, O., moghaddam, M. T., & Vastegani, S. M. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111667 · Cited by 22
Detection of Alzheimer’s Disease Using Logistic Regression and Clock Drawing Errors
Lazarova, S., Григорова, Д., Petrova‐Antonova, D., & Initiative, A. D. N. (2023) · Brain Sciences · doi:10.3390/brainsci13081139 · Cited by 22
“For instance, screening based on speech patterns [26,27] and mobile applications [28,29] leverages digital versions of widely used cognitive tests.”
Background
Metadata
- Authors
- Fristed, E., Skirrow, C., Meszaros, M., Lenain, R., Meepegama, U., Papp, K. V., Ropacki, M., & Weston, J.
- Affiliations
- Novoic Ltd , London, N1 7EU , UK
- Brigham and Women's Hospital (US)
- Strategic Global Research & Development , Temecula, California, 94019 , USA
- Corresponding author
- Skirrow, Caroline
- ORCID
- Venue
- Brain Communications
- Publisher
- Oxford University Press (OUP)
- Published
- 2022-09-01
- Volume
- 4
- Issue
- 5
- Pages
- fcac231-fcac231
- ISSN
- 2632-1297 (ISSN-L)
- PMC
- PMC9639797
- OpenAlex
- W4306403642
- Cited by
- 29
- References
- 55
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 8 · 2023: 2
- FWCI
- 3.26
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Brain Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Bristol Research (University of Bristol) (submittedVersion, cc-by)
- Explore Bristol Research (submittedVersion, cc-by)
- Funders
- Novoic
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
- Keywords
- Alzheimer's disease, automated speech analysis, artificial intelligence, mild cognitive impairment, early detection, story recall, primary care screening, telemedicine, cognitive screening, false positives
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.